(firstQuint)An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis.

 This was an open-label, multicenter extension study that was conducted to evaluate the safety and efficacy of etanercept in the treatment of adult subjects with AS who had completed study 0881A3-311-EU.

 The study consisted of an open-label treatment period of up to approximately 96 weeks.

.

 An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis@highlight

The primary objective of this study was to determine the long-term safety of etanercept in adults with AS who had completed study 0881A3-311-EU.

